Intravesical instillation of pirarubicin for preventing postoperative recurrence of superficial bladder cancer in 132 patients

Chinese Journal of Clinical Oncology

Volumn 32, Issue 21, 2005, Pages 1245-1247

  Li, Ningchen ^a   Xiao, Yunxiang ^a   Song, Yi ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Bladder Cancer; Instillation; Intravesical; Pirarubicin

Indexed keywords

PIRARUBICIN;

ABNORMAL URINE COMPOSITION; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PREVENTION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CYSTOSCOPY; DRUG EFFICACY; DRUG INSTILLATION; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE COMPLICATION; SUPERFICIAL CANCER; TRANSITIONAL CELL CARCINOMA; URINARY IRRITATION;

EID: 29244489765     PISSN: 10008179     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Lamm DL. Prophylaxis for recurrent transitional cell carcinoma[J]. Urology, 1991, 37(suppl 5): 21-23
2. Lamm DL. Comparison of BCG with other intravesical agents [J]. Urology, 1991, 37(Suppl 5): 30-32
3. Akaza H, Niijima T, Hisamatsu T, et al. Comparative investigation on use of (2)-4-O-terahydropyranyl-adrimycin as intravesical chemotherapy for superficial bladder tumors [J]. Urology, 1988, 32(2): 141-145
4. Lamm DL, Blumenstein BA, Crawford ED, et al. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder[J]. N Engl J Med, 1991, 325(17): 1205-1209
5. Yamamoto Y, Nasu Y, Saika T, et al. The absorption of pirarubicin instilled intravesically immediately after transurethral resection of superficial bladder cancer[J]. BJU Int, 2000, 86: 802-804
6. Okamura K, Ono Y, Kinukawa T, et al. Randomized study of single early instillation of (2″R)-4′-O-tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma[J]. Cancer, 2002, 94: 2363-2368